Find a medicine Medicines Veterinary Medicines Generics Advanced Search I want to: Report an issue Get fees info See guides & forms Visit the Innovation Office Latest updates All updates Safety notices Safety Notices Medicines Safety Notices 3rd Party Publications 25.05.2018 Tivicay (dolutegravir), Triumeq (dolutegravir, abacavir, lamivudine), Juluca (dolutegravir, rilpivirine) - Important Safety Information from Viiv Healthcare as approved by the HPRA Safety Notices Medicines Safety Notices 3rd Party Publications 24.05.2018 HPRA MIMS Article May 2018 Valproate (Epilim) - New contraindications, strengthened warnings and measures to prevent exposure during pregnancy Safety Notices Medicines Safety Notices 3rd Party Publications 24.05.2018 HPRA MIMS Article February 2018 Educational Materials and Tools published on HPRA website Safety Notices Medicines Safety Notices 3rd Party Publications 24.05.2018 HPRA MIMS article January 2018 Quinine. Reminder of safety profile and potential drug drug interactions particularly where used for nocturanl cramps Safety Notices Medicines Safety Notices 3rd Party Publications 24.05.2018 HPRA MIMS Article December 2017 New CPD e-learning module on reporting suspected adverse drug reactions Publications & Forms About Us Publications & Forms Guidance Documents 22.05.2018 Guide to the Notification System for Exempt Medicinal Products Safety Notices Medical Devices Safety Information Safety Notices Warning 22.05.2018 IntelliVue MX40 Patient Monitor. Priority 2 – Warning View all updates » Safety Notices Medicines Safety Notices 3rd Party Publications 25.05.2018 Tivicay (dolutegravir), Triumeq (dolutegravir, abacavir, lamivudine), Juluca (dolutegravir, rilpivirine) - Important Safety Information from Viiv Healthcare as approved by the HPRA Safety Notices Medicines Safety Notices 3rd Party Publications 24.05.2018 HPRA MIMS Article May 2018 Valproate (Epilim) - New contraindications, strengthened warnings and measures to prevent exposure during pregnancy Safety Notices Medicines Safety Notices 3rd Party Publications 24.05.2018 HPRA MIMS Article February 2018 Educational Materials and Tools published on HPRA website Safety Notices Medicines Safety Notices 3rd Party Publications 24.05.2018 HPRA MIMS article January 2018 Quinine. Reminder of safety profile and potential drug drug interactions particularly where used for nocturanl cramps Safety Notices Medicines Safety Notices 3rd Party Publications 24.05.2018 HPRA MIMS Article December 2017 New CPD e-learning module on reporting suspected adverse drug reactions Safety Notices Medical Devices Safety Information Safety Notices Warning 22.05.2018 IntelliVue MX40 Patient Monitor. Priority 2 – Warning Safety Notices Medicines Safety Notices 3rd Party Publications 17.05.2018 Xgeva (denosumab) - Important Safety Information from Amgen as approved by the HPRA (May 2018) View all updates » The HPRA for: Patients & Public Healthcare Professionals Industry Innovation Office Brexit Educational Material Emergency Medicines Portal Publications and Forms Newsletters Report Suspicious Activities Vaccines Generic & Interchangeable Medicines